Ctt Pharmaceutical Holdings, Inc. (CTTH): who owns it and who trades it
As of Nov 16, 2026, CTTH insiders reported 20 purchases worth $16.4K in the last 12 months. The largest buyer was Ctt Pharmaceutical Holdings, Inc. (CEO), with $16.4K.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, CTTH insiders reported $16.4K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 1,500 | $0.05 | $81 | Form 4 |
| Nov 4, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 9,000 | $0.05 | $450 | Form 4 |
| Oct 26, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 5,880 | $0.06 | $335 | Form 4 |
| Oct 15, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 2,000 | $0.06 | $114 | Form 4 |
| Oct 6, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 3,700 | $0.06 | $204 | Form 4 |
| Sep 28, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 3,400 | $0.06 | $204 | Form 4 |
| Sep 22, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 10,100 | $0.05 | $505 | Form 4 |
| Sep 16, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 10,900 | $0.05 | $545 | Form 4 |
| Sep 10, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 3,500 | $0.05 | $175 | Form 4 |
| Sep 4, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 9,800 | $0.05 | $490 | Form 4 |
| Sep 2, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 3,000 | $0.05 | $150 | Form 4 |
| Aug 31, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 3,500 | $0.05 | $175 | Form 4 |
| Aug 24, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 2,100 | $0.06 | $126 | Form 4 |
| Aug 20, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 11,500 | $0.05 | $575 | Form 4 |
| Aug 19, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 10,000 | $0.06 | $600 | Form 4 |
| Aug 14, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 1,800 | $0.06 | $108 | Form 4 |
| Aug 7, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 7,700 | $0.07 | $539 | Form 4 |
| Dec 17, 2025 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 8,300 | $0.06 | $498 | Form 4 |
| Nov 20, 2025 | Ctt Pharmaceutical Holdings, Inc. | Director | Purchase | 200,000 | $0.04 | $8K | Form 4 |
| Nov 20, 2025 | Ctt Pharmaceutical Holdings, Inc. | CEO | Purchase | 62,900 | $0.04 | $2.5K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Ctt Pharmaceutical Holdings, Inc. | CEO | $16.4K | – | Nov 12, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CTTH short interest
Low short interest. Less than 0.1% of CTTH shares are sold short. Over the last 12 reports the number of shares short went up 1124%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 19,151 CTTH shares were sold short, 0.0% of the shares outstanding, up 5.5% from the report before. At the average daily volume of 19,600 shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 19,151 | 0.03% | +6% | 19,600 | 1.0 |
| Oct 15, 2026 | 18,151 | 0.03% | -1% | 14,329 | 1.3 |
| Sep 30, 2026 | 18,341 | 0.03% | +76% | 57,700 | 1.0 |
| Sep 15, 2026 | 10,447 | 0.02% | +107% | 67,566 | 1.0 |
| Aug 31, 2026 | 5,050 | – | -1% | 84,348 | 1.0 |
| Aug 14, 2026 | 5,117 | – | -74% | 85,767 | 1.0 |
| Jul 31, 2026 | 19,700 | – | +4297% | 98,863 | 1.0 |
| Jul 15, 2026 | 448 | – | -96% | 22,515 | 1.0 |
| Jun 30, 2026 | 12,065 | – | -0% | 14,161 | 1.0 |
| Jun 15, 2026 | 12,118 | – | -39% | 6,649 | 1.8 |
| May 29, 2026 | 19,886 | – | +1171% | 40,023 | 1.0 |
| May 15, 2026 | 1,564 | – | +10% | 55,568 | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
CTT Pharmaceutical Holdings company events
CTT Pharmaceutical Holdings filed 5 reports on Form 8-K in the last 12 months, 2 of them about an important change (auditor). The latest was on Oct 30, 2026.
- Oct 30, 2026AnnouncementCTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) : As previously reported on Form 8-K filed October 7, 2026, Holt & Patterson, our prior certifying public accountant resigned. Filing
- Oct 9, 2026AuditorChanges in Registrant’s Certifying Accountant. Filing
- Oct 7, 2026AuditorChanges in Registrant’s Certifying Accountant. Filing
- Sep 23, 2026AgreementSigned an important agreement. Filing
- Aug 12, 2026AnnouncementCTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) received a continuation-in-part (CIP) approval from The United States Patent Office for the company’s micelle delivery technology. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Questions about Ctt Pharmaceutical Holdings, Inc. (CTTH) stock
Are CTTH insiders buying or selling?
In the last 12 months, CTTH insiders reported 20 open-market purchases worth $16.4K and no sales. The latest trade was on Nov 12, 2026. See every trade.
What is the short interest in CTTH?
As of Oct 30, 2026, 19,151 CTTH shares were sold short, 0.0% of the shares outstanding, up 5.5% from the report before. At the average daily volume of 19,600 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.